e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Monitoring exacerbations of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD assessment test correlation with the increase of the inflammatory markers in COPD exacerbations
Z. I. Fratila, I. Iovan, D. Vancea (Timisoara, Romania)
Source:
Annual Congress 2011 - Monitoring exacerbations of airway diseases
Session:
Monitoring exacerbations of airway diseases
Session type:
Thematic Poster Session
Number:
898
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. I. Fratila, I. Iovan, D. Vancea (Timisoara, Romania). COPD assessment test correlation with the increase of the inflammatory markers in COPD exacerbations. Eur Respir J 2011; 38: Suppl. 55, 898
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Features of COPD in correlation with COPD assessment test
Source: International Congress 2019 – Clinical implications of COPD management
Year: 2019
The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
An evaluation of exacerbations in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap
Source: Eur Respir J 2014; 43: 421-429
Year: 2013
COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD
Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020
Year: 2021
Evaluation of markers for exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 283s
Year: 2005
Clinical value of C-reactive protein in severe acute exacerbations of COPD
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
Catabolic/anabolic balance in patients with COPD exacerbation
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004
The relationship of exacerbations and lung function decline to radiologic characteristics in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005
Phenotypic markers of asthma and COPD at the tissue level
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005
Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005
Longitudinal changes in the nature, severity and frequency of COPD exacerbations
Source: Eur Respir J 2003 Dec 01;22(6):931-936
Year: 2003
Significance of quantitative radiological phenotypes of COPD on BODE index
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Routine blood test biomarkers and their association with exacerbations in COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Early phenotypes of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Different data in COPD
Year: 2015
Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept